Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease

We are currently investigating colonic biopsies from patients with Parkinson disease (PD) and healthy controls (HC) participating in the Discovery study.1 Our findings partially agree with those of Visanji etal.2 Specifically, we found that immunohistochemistry using antibodies for nonphosphorylated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2015-09, Vol.85 (9), p.834-835
Hauptverfasser: Ruffmann, Claudio, Parkkinen, Laura
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 835
container_issue 9
container_start_page 834
container_title Neurology
container_volume 85
creator Ruffmann, Claudio
Parkkinen, Laura
description We are currently investigating colonic biopsies from patients with Parkinson disease (PD) and healthy controls (HC) participating in the Discovery study.1 Our findings partially agree with those of Visanji etal.2 Specifically, we found that immunohistochemistry using antibodies for nonphosphorylated but also phosphorylated forms of alpha -synuclein does not allow accurate and reliable distinction between PD and HC groups.
doi_str_mv 10.1212/WNL.0000000000001904
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765944801</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1732595488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4881-7ca8f83a929a5760d1e4e6ba5c4703c65fb6d5a35565b94770591cb9fb8437803</originalsourceid><addsrcrecordid>eNqNkctqGzEUhkVJaZy0bxCCltlMovtlWUxuYJJCU9rdoJE1RLE8cnU8GD9WXqTPFOXStGQVbY44fOeXOB9CB5QcU0bZyc-r2TH571BLxAc0oZKpRnH2awdNCGGm4UabXbQHcFcZybT9hHZZBYRRcoK-T3PKQ_R4OfoMLuE_9w1sh9GnEAecnF8AhlXwsY8-rrfYAXa4i3npyiIU3OeCv9VrHCAPeB4hOAif0cfeJQhfXuo--nF2ejO9aGbX55fTr7PGC2Noo70zveHOMuukVmROgwiqc9ILTbhXsu_UXDoupZKdFVoTaanvbN8ZwbUhfB8dPeeuSv49Bli3ywg-pOSGkEdoqVbSCmEIfQfKmbSy_usdKDF11Yzpiopn1JcMUELfrkqsm9m2lLSPktoqqX0rqY4dvrwwdsswfx36a-Vf7iandSiwSOMmlPY2uLS-fcpTlIqGVZ_EEkqa2mGUPwAZ9Zt8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708904227</pqid></control><display><type>article</type><title>Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Ruffmann, Claudio ; Parkkinen, Laura</creator><creatorcontrib>Ruffmann, Claudio ; Parkkinen, Laura</creatorcontrib><description>We are currently investigating colonic biopsies from patients with Parkinson disease (PD) and healthy controls (HC) participating in the Discovery study.1 Our findings partially agree with those of Visanji etal.2 Specifically, we found that immunohistochemistry using antibodies for nonphosphorylated but also phosphorylated forms of alpha -synuclein does not allow accurate and reliable distinction between PD and HC groups.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000001904</identifier><identifier>PMID: 26324865</identifier><language>eng</language><publisher>United States: American Academy of Neurology</publisher><subject>alpha-Synuclein - metabolism ; Biopsy ; Colon - metabolism ; Female ; Humans ; Intestinal Mucosa - metabolism ; Male ; Parkinson Disease - diagnosis</subject><ispartof>Neurology, 2015-09, Vol.85 (9), p.834-835</ispartof><rights>2015 American Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4881-7ca8f83a929a5760d1e4e6ba5c4703c65fb6d5a35565b94770591cb9fb8437803</citedby><cites>FETCH-LOGICAL-c4881-7ca8f83a929a5760d1e4e6ba5c4703c65fb6d5a35565b94770591cb9fb8437803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26324865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruffmann, Claudio</creatorcontrib><creatorcontrib>Parkkinen, Laura</creatorcontrib><title>Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease</title><title>Neurology</title><addtitle>Neurology</addtitle><description>We are currently investigating colonic biopsies from patients with Parkinson disease (PD) and healthy controls (HC) participating in the Discovery study.1 Our findings partially agree with those of Visanji etal.2 Specifically, we found that immunohistochemistry using antibodies for nonphosphorylated but also phosphorylated forms of alpha -synuclein does not allow accurate and reliable distinction between PD and HC groups.</description><subject>alpha-Synuclein - metabolism</subject><subject>Biopsy</subject><subject>Colon - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Male</subject><subject>Parkinson Disease - diagnosis</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkctqGzEUhkVJaZy0bxCCltlMovtlWUxuYJJCU9rdoJE1RLE8cnU8GD9WXqTPFOXStGQVbY44fOeXOB9CB5QcU0bZyc-r2TH571BLxAc0oZKpRnH2awdNCGGm4UabXbQHcFcZybT9hHZZBYRRcoK-T3PKQ_R4OfoMLuE_9w1sh9GnEAecnF8AhlXwsY8-rrfYAXa4i3npyiIU3OeCv9VrHCAPeB4hOAif0cfeJQhfXuo--nF2ejO9aGbX55fTr7PGC2Noo70zveHOMuukVmROgwiqc9ILTbhXsu_UXDoupZKdFVoTaanvbN8ZwbUhfB8dPeeuSv49Bli3ywg-pOSGkEdoqVbSCmEIfQfKmbSy_usdKDF11Yzpiopn1JcMUELfrkqsm9m2lLSPktoqqX0rqY4dvrwwdsswfx36a-Vf7iandSiwSOMmlPY2uLS-fcpTlIqGVZ_EEkqa2mGUPwAZ9Zt8</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ruffmann, Claudio</creator><creator>Parkkinen, Laura</creator><general>American Academy of Neurology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20150901</creationdate><title>Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease</title><author>Ruffmann, Claudio ; Parkkinen, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4881-7ca8f83a929a5760d1e4e6ba5c4703c65fb6d5a35565b94770591cb9fb8437803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>alpha-Synuclein - metabolism</topic><topic>Biopsy</topic><topic>Colon - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Male</topic><topic>Parkinson Disease - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruffmann, Claudio</creatorcontrib><creatorcontrib>Parkkinen, Laura</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruffmann, Claudio</au><au>Parkkinen, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>85</volume><issue>9</issue><spage>834</spage><epage>835</epage><pages>834-835</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><abstract>We are currently investigating colonic biopsies from patients with Parkinson disease (PD) and healthy controls (HC) participating in the Discovery study.1 Our findings partially agree with those of Visanji etal.2 Specifically, we found that immunohistochemistry using antibodies for nonphosphorylated but also phosphorylated forms of alpha -synuclein does not allow accurate and reliable distinction between PD and HC groups.</abstract><cop>United States</cop><pub>American Academy of Neurology</pub><pmid>26324865</pmid><doi>10.1212/WNL.0000000000001904</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2015-09, Vol.85 (9), p.834-835
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_1765944801
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects alpha-Synuclein - metabolism
Biopsy
Colon - metabolism
Female
Humans
Intestinal Mucosa - metabolism
Male
Parkinson Disease - diagnosis
title Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A46%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colonic%20mucosal%20%CE%B1-synuclein%20lacks%20specificity%20as%20a%20biomarker%20for%20Parkinson%20disease&rft.jtitle=Neurology&rft.au=Ruffmann,%20Claudio&rft.date=2015-09-01&rft.volume=85&rft.issue=9&rft.spage=834&rft.epage=835&rft.pages=834-835&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000001904&rft_dat=%3Cproquest_cross%3E1732595488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1708904227&rft_id=info:pmid/26324865&rfr_iscdi=true